市場調査レポート

商品コード

1633057

細胞療法の世界市場分析と予測（～2033年）：タイプ、製品、サービス、技術、用途、エンドユーザー、プロセス、方法、ステージ

Cell Therapy Market Analysis and Forecast to 2033: Type, Product, Services, Technology, Application, End User, Process, Mode, Stage

出版日: 2025年01月13日
発行: Global Insight Services
ページ情報: 英文 352 Pages
納期: 3～5営業日

価格

Single User License

USD 4,750 711,740円

PDFを1名にご利用頂けるライセンスです。レポート内容の抜粋に関しては、組織内で共有いただけます。

Site License

USD 5,750 861,580円

PDF、Excelを地理上の同一事業所内の方にご利用頂けるライセンスです。レポート内容の抜粋に関しては、組織内で共有いただけます。

Enterprise License

USD 6,750 1,011,420円

PDF、Excelを同一企業の世界中の方にご利用頂けるライセンスです。レポート内容の抜粋に関しては、組織内外で共有いただけます。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=149.84円

全表示
概要
目次

概要

サンプル依頼リストに入れる

世界の細胞療法の市場規模は、2023年の78億米ドルから2033年には301億米ドルに拡大すると予測され、CAGRは14.8%と堅調な成長を反映する見通しです。

細胞療法市場には、損傷した組織や臓器を修復、置換、再生するために生きた細胞を使用する治療の開発、商業化、応用が含まれます。この急速に発展している分野には、バイオテクノロジーの進歩や再生医療への投資の増加により、がんから変性疾患まで様々な疾患を対象とした、自己細胞療法、同種細胞療法、幹細胞療法、遺伝子編集技術が含まれます。

市場は、再生医療の進歩と慢性疾患の有病率の増加に牽引され、成長を経験しています。様々なセグメントの中で、幹細胞療法は幅広い疾患の治療が可能であり、臨床試験も進行中であることから、トップクラスのサブセグメントとして浮上しています。CAR-T細胞療法は、がん治療における有望な実績と最近のFDA承認により、市場の魅力を高めています。地域別では北米が市場をリードしていますが、これは強力な医療インフラと研究開発への多額の投資が背景にあります。欧州は、良好な規制の枠組みや先進的な治療法の採用増加に支えられ、第2位の地位を占めています。これらの地域の中では、米国とドイツが、最先端の研究施設と政府の支援政策により、それぞれトップの実績を上げています。技術革新と戦略的提携の進展により、細胞療法市場はさらなる拡大が見込まれています。

2023年、細胞療法市場は堅調な力学を示し、推定市場規模は世界で1億2,000万件の処置数に達し、2033年には2億5,000万件に拡大すると予測されます。同種細胞療法は、その拡張性と製造コストの削減により55%のシェアを占め、一方自家細胞療法は、その個別化治療アプローチが支持され45%のシェアを占めています。がん分野は依然として主要な応用分野であり、市場シェアの60％を占め、次いで心血管疾患が20％、筋骨格系疾患が15％となっています。ノバルティス、ギリアド・サイエンシズ、ブルーバード・バイオなどの主要企業が中心的な存在であり、中でもノバルティスはCAR-T細胞療法でリードしており、市場動向と競争力に影響を与えています。

規制状況は、FDAや市場情勢のような厳しいガイドラインによって特徴付けられ、特に承認スケジュールやコンプライアンスコストの面で市場運営に大きな影響を与えています。治療開発におけるAIと機械学習の統合は、有効性の向上と市場投入期間の短縮につながると予想されます。有望な成長にもかかわらず、高額な治療費や複雑な製造工程などの課題は残っています。それにもかかわらず、新興市場と政府の資金援助イニシアティブは、細胞療法市場の前向きな見通しを強調し、拡大のための有利な機会を提供しています。

細胞療法市場はダイナミックな地域情勢を示し、北米が大きなシェアを占めています。この優位性は、強固な医療インフラの存在、研究開発への多額の投資、良好な規制環境に起因します。特に米国は、バイオテクノロジーの進歩における先駆的な役割と、学術・研究機関の強力なネットワークによって、最前線に立っています。さらに、最先端の医療技術の導入に積極的な姿勢が、細胞療法領域でのリーダーシップを後押ししています。

欧州は、ドイツ、英国、フランスといった国々が市場をリードしており、北米の後に続いています。この地域は、確立された医療システムと技術革新に重点を置くという利点があります。欧州政府の支援政策と再生医療研究への資金援助は、市場の成長見通しをさらに高めています。さらに、欧州では学術界、産業界、規制機関の連携が、細胞療法の開発と商業化を促進する環境を育んでいます。

アジア太平洋は、急速な経済成長と医療支出の増加に後押しされ、細胞療法市場の重要な地域として台頭してきています。中国、日本、韓国などの国々はバイオテクノロジーやライフサイエンスに多額の投資を行っており、細胞ベースの治療の可能性を活用しようとしています。この地域の患者数は多く、慢性疾患の有病率も高まっていることから、市場拡大の好機が広がっています。さらに、アジア太平洋の規制状況は徐々に進化しており、承認プロセスを合理化し、細胞療法分野のイノベーションを促進する取り組みが進められています。

ラテンアメリカと中東・アフリカは、現在のところ世界市場におけるシェアは小さいものの、細胞療法の導入が徐々に増加しています。ラテンアメリカではブラジルとメキシコが最先端を走っていますが、これは先進的な治療法に対する意識の高まりと、医療・インフラを強化する政府の取り組みが背景にあります。同様に中東・アフリカでは、アラブ首長国連邦や南アフリカなどの国々が医療へのアクセス改善や医療研究への投資で躍進しており、細胞療法市場の今後の成長に道を開いています。

概要
北米
- 米国
- カナダ
欧州
- 英国
- ドイツ
- フランス
- スペイン
- イタリア
- オランダ
- スウェーデン
- スイス
- デンマーク
- フィンランド
- ロシア
- その他欧州
アジア太平洋
- 中国
- インド
- 日本
- 韓国
- オーストラリア
- シンガポール
- インドネシア
- 台湾
- マレーシア
- その他アジア太平洋
ラテンアメリカ
- ブラジル
- メキシコ
- アルゼンチン
- その他ラテンアメリカ
中東・アフリカ
- サウジアラビア
- アラブ首長国連邦
- 南アフリカ
- その他中東・アフリカ

第17章競合情勢

概要
市場シェア分析
主要企業のポジショニング
競合リーダーシップマッピング
ベンダーベンチマーキング
開発戦略のベンチマーキング

第18章企業プロファイル

Bluebird Bio
Sangamo Therapeutics
Adaptimmune Therapeutics
Atara Biotherapeutics
Cellectis
Fate Therapeutics
Gamida Cell
Kiadis Pharma
Mesoblast
Orchard Therapeutics
Poseida Therapeutics
Precision BioSciences
Regenxbio
Rubius Therapeutics
Sorrento Therapeutics
TCR2 Therapeutics
Unum Therapeutics
Vericel
Ziopharm Oncology
Allogene Therapeutics

Product Code: GIS21212

The cell therapy market is anticipated to expand from $7.8 billion in 2023 to $30.1 billion by 2033, driven by a CAGR of 14.8%, reflecting robust growth.

The cell therapy market encompasses the development, commercialization, and application of treatments that use living cells to repair, replace, or regenerate damaged tissues and organs. This rapidly evolving sector includes autologous and allogeneic therapies, stem cell treatments, and gene-editing technologies, targeting a range of conditions from cancer to degenerative diseases, driven by advancements in biotechnology and increasing investment in regenerative medicine.

The market is witnessing growth, driven by advancements in regenerative medicine and increasing prevalence of chronic diseases. Among the various segments, stem cell therapy emerges as the top-performing sub-segment, owing to its potential to treat a wide array of conditions and its ongoing clinical trials. CAR-T cell therapy follows as the second-highest performing sub-segment, with its promising results in cancer treatment and recent FDA approvals enhancing its market appeal. Geographically, North America leads the market, attributed to its strong healthcare infrastructure and substantial investment in research and development. Europe holds the position of the second-highest performing region, supported by favorable regulatory frameworks and increasing adoption of advanced therapies. Within these regions, the United States and Germany are the top-performing countries, respectively, due to their cutting-edge research facilities and supportive government policies. The cell therapy market is poised for further expansion as innovations and strategic collaborations continue to unfold.

In 2023, the Cell Therapy Market demonstrated robust dynamics, with an estimated market volume reaching 120 million procedures globally, projected to expand to 250 million by 2033. The allogeneic segment commands the largest market share at 55%, driven by its scalability and reduced manufacturing costs, while the autologous segment holds a 45% share, favored for its personalized treatment approach. The oncology sector remains the predominant application area, accounting for 60% of the market share, followed by cardiovascular and musculoskeletal disorders at 20% and 15%, respectively. Key players such as Novartis, Gilead Sciences, and Bluebird Bio are pivotal, with Novartis leading in CAR-T cell therapies, influencing market trends and competitive dynamics.

The regulatory landscape is characterized by stringent guidelines from entities like the FDA and EMA, which significantly impact market operations, particularly in terms of approval timelines and compliance costs. The integration of AI and machine learning in therapy development is anticipated to enhance efficacy and reduce time-to-market. Despite promising growth, challenges such as high treatment costs and complex manufacturing processes remain. Nonetheless, emerging markets and government funding initiatives offer lucrative opportunities for expansion, underscoring a positive outlook for the Cell Therapy Market.

The cell therapy market exhibits a dynamic regional landscape, with North America commanding a substantial share. This dominance is attributed to the presence of a robust healthcare infrastructure, significant investment in research and development, and a favorable regulatory environment. The United States, in particular, stands at the forefront, driven by its pioneering role in biotechnological advancements and a strong network of academic and research institutions. Furthermore, the region's proactive stance in adopting cutting-edge medical technologies fuels its leadership in the cell therapy domain.

Europe follows closely, with countries like Germany, the United Kingdom, and France spearheading the market. The region benefits from a well-established healthcare system and a strong emphasis on innovation. European governments' supportive policies and funding for regenerative medicine research further enhance the market's growth prospects. Additionally, the collaboration between academia, industry, and regulatory bodies in Europe fosters a conducive environment for the development and commercialization of cell therapies.

The Asia Pacific region is emerging as a significant player in the cell therapy market, propelled by rapid economic growth and increasing healthcare expenditure. Countries such as China, Japan, and South Korea are investing heavily in biotechnology and life sciences, aiming to capitalize on the therapeutic potential of cell-based treatments. The region's large patient pool and growing prevalence of chronic diseases present lucrative opportunities for market expansion. Moreover, the regulatory landscape in Asia Pacific is gradually evolving, with efforts to streamline approval processes and encourage innovation in the field of cell therapy.

Latin America and the Middle East and Africa, while currently representing smaller shares of the global market, are witnessing a gradual uptick in cell therapy adoption. In Latin America, Brazil and Mexico are at the forefront, driven by increasing awareness of advanced therapeutic options and government initiatives to boost healthcare infrastructure. Similarly, in the Middle East and Africa, countries such as the United Arab Emirates and South Africa are making strides in improving healthcare access and investing in medical research, thereby paving the way for future growth in the cell therapy market.

Key Companies

Bluebird Bio, Sangamo Therapeutics, Adaptimmune Therapeutics, Atara Biotherapeutics, Cellectis, Fate Therapeutics, Gamida Cell, Kiadis Pharma, Mesoblast, Orchard Therapeutics, Poseida Therapeutics, Precision Bio Sciences, Regenxbio, Rubius Therapeutics, Sorrento Therapeutics, TCR2 Therapeutics, Unum Therapeutics, Vericel, Ziopharm Oncology, Allogene Therapeutics

Sources

U.S. Food and Drug Administration - Center for Biologics Evaluation and Research, European Medicines Agency, National Institutes of Health - National Center for Advancing Translational Sciences, World Health Organization - Global Observatory on Health R&D, International Society for Cellular Therapy, International Society for Stem Cell Research, Alliance for Regenerative Medicine, National Institute for Health and Care Excellence (NICE), Biotechnology Innovation Organization, Cell & Gene Therapy Catapult (UK), Japan Agency for Medical Research and Development, Centre for Commercialization of Regenerative Medicine (Canada), International Society for Cell & Gene Therapy, U.S. National Institute of Standards and Technology, European Federation of Pharmaceutical Industries and Associations, U.S. Department of Health and Human Services, California Institute for Regenerative Medicine, Harvard Stem Cell Institute, International Conference on Cell and Stem Cell Research, World Stem Cell Summit

Research Scope

Estimates and forecasts the overall market size across type, application, and region.
Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

1: Cell Therapy Market Overview

1.1 Objectives of the Study
1.2 Cell Therapy Market Definition and Scope of the Report
1.3 Report Limitations
1.4 Years & Currency Considered in the Study
1.5 Research Methodologies
- 1.5.1 Secondary Research
- 1.5.2 Primary Research
- 1.5.3 Market Size Estimation: Top-Down Approach
- 1.5.4 Market Size Estimation: Bottom-Up Approach
- 1.5.5 Data Triangulation and Validation

2: Executive Summary

2.1 Summary
2.2 Key Opinion Leaders
2.3 Key Highlights of the Market, by Type
2.4 Key Highlights of the Market, by Product
2.5 Key Highlights of the Market, by Services
2.6 Key Highlights of the Market, by Technology
2.7 Key Highlights of the Market, by Application
2.8 Key Highlights of the Market, by End User
2.9 Key Highlights of the Market, by Process
2.10 Key Highlights of the Market, by Mode
2.11 Key Highlights of the Market, by Stage
2.12 Key Highlights of the Market, by North America
2.13 Key Highlights of the Market, by Europe
2.14 Key Highlights of the Market, by Asia-Pacific
2.15 Key Highlights of the Market, by Latin America
2.16 Key Highlights of the Market, by Middle East
2.17 Key Highlights of the Market, by Africa

3: Premium Insights on the Market

3.1 Market Attractiveness Analysis, by Region
3.2 Market Attractiveness Analysis, by Type
3.3 Market Attractiveness Analysis, by Product
3.4 Market Attractiveness Analysis, by Services
3.5 Market Attractiveness Analysis, by Technology
3.6 Market Attractiveness Analysis, by Application
3.7 Market Attractiveness Analysis, by End User
3.8 Market Attractiveness Analysis, by Process
3.9 Market Attractiveness Analysis, by Mode
3.10 Market Attractiveness Analysis, by Stage
3.11 Market Attractiveness Analysis, by North America
3.12 Market Attractiveness Analysis, by Europe
3.13 Market Attractiveness Analysis, by Asia-Pacific
3.14 Market Attractiveness Analysis, by Latin America
3.15 Market Attractiveness Analysis, by Middle East
3.16 Market Attractiveness Analysis, by Africa

4: Cell Therapy Market Outlook

4.1 Cell Therapy Market Segmentation
4.2 Market Dynamics
- 4.2.1 Market Drivers
- 4.2.2 Market Trends
- 4.2.3 Market Restraints
- 4.2.4 Market Opportunities
4.3 Porters Five Forces Analysis
- 4.3.1 Threat of New Entrants
- 4.3.2 Threat of Substitutes
- 4.3.3 Bargaining Power of Buyers
- 4.3.4 Bargaining Power of Supplier
- 4.3.5 Competitive Rivalry
4.4 PESTLE Analysis
4.5 Value Chain Analysis
4.6 4Ps Model
4.7 ANSOFF Matrix

5: Cell Therapy Market Strategy

5.1 Parent Market Analysis
5.2 Supply-Demand Analysis
5.3 Consumer Buying Interest
5.4 Case Study Analysis
5.5 Pricing Analysis
5.6 Regulatory Landscape
5.7 Supply Chain Analysis
5.8 Competition Product Analysis
5.9 Recent Developments

6: Cell Therapy Market Size

6.1 Cell Therapy Market Size, by Value
6.2 Cell Therapy Market Size, by Volume

7: Cell Therapy Market, by Type

7.1 Market Overview
7.2 Autologous
- 7.2.1 Key Market Trends & Opportunity Analysis
- 7.2.2 Market Size and Forecast, by Region
7.3 Allogeneic
- 7.3.1 Key Market Trends & Opportunity Analysis
- 7.3.2 Market Size and Forecast, by Region
7.4 Xenogeneic
- 7.4.1 Key Market Trends & Opportunity Analysis
- 7.4.2 Market Size and Forecast, by Region
7.5 Syngeneic
- 7.5.1 Key Market Trends & Opportunity Analysis
- 7.5.2 Market Size and Forecast, by Region
7.6 Others
- 7.6.1 Key Market Trends & Opportunity Analysis
- 7.6.2 Market Size and Forecast, by Region

8: Cell Therapy Market, by Product

8.1 Market Overview
8.2 Stem Cell Therapy
- 8.2.1 Key Market Trends & Opportunity Analysis
- 8.2.2 Market Size and Forecast, by Region
8.3 Non-Stem Cell Therapy
- 8.3.1 Key Market Trends & Opportunity Analysis
- 8.3.2 Market Size and Forecast, by Region
8.4 Immune Cell Therapy
- 8.4.1 Key Market Trends & Opportunity Analysis
- 8.4.2 Market Size and Forecast, by Region
8.5 Gene-Modified Cell Therapy
- 8.5.1 Key Market Trends & Opportunity Analysis
- 8.5.2 Market Size and Forecast, by Region
8.6 Others
- 8.6.1 Key Market Trends & Opportunity Analysis
- 8.6.2 Market Size and Forecast, by Region

9: Cell Therapy Market, by Services

9.1 Market Overview
9.2 Manufacturing
- 9.2.1 Key Market Trends & Opportunity Analysis
- 9.2.2 Market Size and Forecast, by Region
9.3 Storage
- 9.3.1 Key Market Trends & Opportunity Analysis
- 9.3.2 Market Size and Forecast, by Region
9.4 Distribution
- 9.4.1 Key Market Trends & Opportunity Analysis
- 9.4.2 Market Size and Forecast, by Region
9.5 Consulting
- 9.5.1 Key Market Trends & Opportunity Analysis
- 9.5.2 Market Size and Forecast, by Region
9.6 Quality Assurance
- 9.6.1 Key Market Trends & Opportunity Analysis
- 9.6.2 Market Size and Forecast, by Region
9.7 Regulatory Compliance
- 9.7.1 Key Market Trends & Opportunity Analysis
- 9.7.2 Market Size and Forecast, by Region
9.8 Others
- 9.8.1 Key Market Trends & Opportunity Analysis
- 9.8.2 Market Size and Forecast, by Region

10: Cell Therapy Market, by Technology

10.1 Market Overview
10.2 CRISPR
- 10.2.1 Key Market Trends & Opportunity Analysis
- 10.2.2 Market Size and Forecast, by Region
10.3 TALEN
- 10.3.1 Key Market Trends & Opportunity Analysis
- 10.3.2 Market Size and Forecast, by Region
10.4 ZFN
- 10.4.1 Key Market Trends & Opportunity Analysis
- 10.4.2 Market Size and Forecast, by Region
10.5 Sleeping Beauty Transposon
- 10.5.1 Key Market Trends & Opportunity Analysis
- 10.5.2 Market Size and Forecast, by Region
10.6 Lentiviral
- 10.6.1 Key Market Trends & Opportunity Analysis
- 10.6.2 Market Size and Forecast, by Region
10.7 Adenoviral
- 10.7.1 Key Market Trends & Opportunity Analysis
- 10.7.2 Market Size and Forecast, by Region
10.8 Others
- 10.8.1 Key Market Trends & Opportunity Analysis
- 10.8.2 Market Size and Forecast, by Region

11: Cell Therapy Market, by Application

11.1 Market Overview
11.2 Oncology
- 11.2.1 Key Market Trends & Opportunity Analysis
- 11.2.2 Market Size and Forecast, by Region
11.3 Cardiovascular
- 11.3.1 Key Market Trends & Opportunity Analysis
- 11.3.2 Market Size and Forecast, by Region
11.4 Neurology
- 11.4.1 Key Market Trends & Opportunity Analysis
- 11.4.2 Market Size and Forecast, by Region
11.5 Orthopedic
- 11.5.1 Key Market Trends & Opportunity Analysis
- 11.5.2 Market Size and Forecast, by Region
11.6 Dermatology
- 11.6.1 Key Market Trends & Opportunity Analysis
- 11.6.2 Market Size and Forecast, by Region
11.7 Ophthalmology
- 11.7.1 Key Market Trends & Opportunity Analysis
- 11.7.2 Market Size and Forecast, by Region
11.8 Hematology
- 11.8.1 Key Market Trends & Opportunity Analysis
- 11.8.2 Market Size and Forecast, by Region
11.9 Others
- 11.9.1 Key Market Trends & Opportunity Analysis
- 11.9.2 Market Size and Forecast, by Region

12: Cell Therapy Market, by End User

12.1 Market Overview
12.2 Hospitals
- 12.2.1 Key Market Trends & Opportunity Analysis
- 12.2.2 Market Size and Forecast, by Region
12.3 Clinics
- 12.3.1 Key Market Trends & Opportunity Analysis
- 12.3.2 Market Size and Forecast, by Region
12.4 Research Institutes
- 12.4.1 Key Market Trends & Opportunity Analysis
- 12.4.2 Market Size and Forecast, by Region
12.5 Biopharmaceutical Companies
- 12.5.1 Key Market Trends & Opportunity Analysis
- 12.5.2 Market Size and Forecast, by Region
12.6 Academic Institutions
- 12.6.1 Key Market Trends & Opportunity Analysis
- 12.6.2 Market Size and Forecast, by Region
12.7 Others
- 12.7.1 Key Market Trends & Opportunity Analysis
- 12.7.2 Market Size and Forecast, by Region

13: Cell Therapy Market, by Process

13.1 Market Overview
13.2 Cell Expansion
- 13.2.1 Key Market Trends & Opportunity Analysis
- 13.2.2 Market Size and Forecast, by Region
13.3 Cell Preservation
- 13.3.1 Key Market Trends & Opportunity Analysis
- 13.3.2 Market Size and Forecast, by Region
13.4 Cell Separation
- 13.4.1 Key Market Trends & Opportunity Analysis
- 13.4.2 Market Size and Forecast, by Region
13.5 Cell Culture
- 13.5.1 Key Market Trends & Opportunity Analysis
- 13.5.2 Market Size and Forecast, by Region
13.6 Cell Engineering
- 13.6.1 Key Market Trends & Opportunity Analysis
- 13.6.2 Market Size and Forecast, by Region
13.7 Others
- 13.7.1 Key Market Trends & Opportunity Analysis
- 13.7.2 Market Size and Forecast, by Region

14: Cell Therapy Market, by Mode

14.1 Market Overview
14.2 In Vivo
- 14.2.1 Key Market Trends & Opportunity Analysis
- 14.2.2 Market Size and Forecast, by Region
14.3 Ex Vivo
- 14.3.1 Key Market Trends & Opportunity Analysis
- 14.3.2 Market Size and Forecast, by Region
14.4 Others
- 14.4.1 Key Market Trends & Opportunity Analysis
- 14.4.2 Market Size and Forecast, by Region

15: Cell Therapy Market, by Stage

15.1 Market Overview
15.2 Preclinical
- 15.2.1 Key Market Trends & Opportunity Analysis
- 15.2.2 Market Size and Forecast, by Region
15.3 Clinical Trials
- 15.3.1 Key Market Trends & Opportunity Analysis
- 15.3.2 Market Size and Forecast, by Region
15.4 Commercialization
- 15.4.1 Key Market Trends & Opportunity Analysis
- 15.4.2 Market Size and Forecast, by Region
15.5 Others
- 15.5.1 Key Market Trends & Opportunity Analysis
- 15.5.2 Market Size and Forecast, by Region

16: Cell Therapy Market, by Region

16.1 Overview
16.2 North America
- 16.2.1 Key Market Trends and Opportunities
- 16.2.2 North America Market Size and Forecast, by Type
- 16.2.3 North America Market Size and Forecast, by Product
- 16.2.4 North America Market Size and Forecast, by Services
- 16.2.5 North America Market Size and Forecast, by Technology
- 16.2.6 North America Market Size and Forecast, by Application
- 16.2.7 North America Market Size and Forecast, by End User
- 16.2.8 North America Market Size and Forecast, by Process
- 16.2.9 North America Market Size and Forecast, by Mode
- 16.2.10 North America Market Size and Forecast, by Stage
- 16.2.11 North America Market Size and Forecast, by Country
- 16.2.12 United States
  - 16.2.9.1 United States Market Size and Forecast, by Type
  - 16.2.9.2 United States Market Size and Forecast, by Product
  - 16.2.9.3 United States Market Size and Forecast, by Services
  - 16.2.9.4 United States Market Size and Forecast, by Technology
  - 16.2.9.5 United States Market Size and Forecast, by Application
  - 16.2.9.6 United States Market Size and Forecast, by End User
  - 16.2.9.7 United States Market Size and Forecast, by Process
  - 16.2.9.8 United States Market Size and Forecast, by Mode
  - 16.2.9.9 United States Market Size and Forecast, by Stage
  - 16.2.9.10 Local Competition Analysis
  - 16.2.9.11 Local Market Analysis
- 16.2.1 Canada
  - 16.2.10.1 Canada Market Size and Forecast, by Type
  - 16.2.10.2 Canada Market Size and Forecast, by Product
  - 16.2.10.3 Canada Market Size and Forecast, by Services
  - 16.2.10.4 Canada Market Size and Forecast, by Technology
  - 16.2.10.5 Canada Market Size and Forecast, by Application
  - 16.2.10.6 Canada Market Size and Forecast, by End User
  - 16.2.10.7 Canada Market Size and Forecast, by Process
  - 16.2.10.8 Canada Market Size and Forecast, by Mode
  - 16.2.10.9 Canada Market Size and Forecast, by Stage
  - 16.2.10.10 Local Competition Analysis
  - 16.2.10.11 Local Market Analysis
16.1 Europe
- 16.3.1 Key Market Trends and Opportunities
- 16.3.2 Europe Market Size and Forecast, by Type
- 16.3.3 Europe Market Size and Forecast, by Product
- 16.3.4 Europe Market Size and Forecast, by Services
- 16.3.5 Europe Market Size and Forecast, by Technology
- 16.3.6 Europe Market Size and Forecast, by Application
- 16.3.7 Europe Market Size and Forecast, by End User
- 16.3.8 Europe Market Size and Forecast, by Process
- 16.3.9 Europe Market Size and Forecast, by Mode
- 16.3.10 Europe Market Size and Forecast, by Stage
- 16.3.11 Europe Market Size and Forecast, by Country
- 16.3.12 United Kingdom
  - 16.3.9.1 United Kingdom Market Size and Forecast, by Type
  - 16.3.9.2 United Kingdom Market Size and Forecast, by Product
  - 16.3.9.3 United Kingdom Market Size and Forecast, by Services
  - 16.3.9.4 United Kingdom Market Size and Forecast, by Technology
  - 16.3.9.5 United Kingdom Market Size and Forecast, by Application
  - 16.3.9.6 United Kingdom Market Size and Forecast, by End User
  - 16.3.9.7 United Kingdom Market Size and Forecast, by Process
  - 16.3.9.8 United Kingdom Market Size and Forecast, by Mode
  - 16.3.9.9 United Kingdom Market Size and Forecast, by Stage
  - 16.3.9.10 Local Competition Analysis
  - 16.3.9.11 Local Market Analysis
- 16.3.1 Germany
  - 16.3.10.1 Germany Market Size and Forecast, by Type
  - 16.3.10.2 Germany Market Size and Forecast, by Product
  - 16.3.10.3 Germany Market Size and Forecast, by Services
  - 16.3.10.4 Germany Market Size and Forecast, by Technology
  - 16.3.10.5 Germany Market Size and Forecast, by Application
  - 16.3.10.6 Germany Market Size and Forecast, by End User
  - 16.3.10.7 Germany Market Size and Forecast, by Process
  - 16.3.10.8 Germany Market Size and Forecast, by Mode
  - 16.3.10.9 Germany Market Size and Forecast, by Stage
  - 16.3.10.10 Local Competition Analysis
  - 16.3.10.11 Local Market Analysis
- 16.3.1 France
  - 16.3.11.1 France Market Size and Forecast, by Type
  - 16.3.11.2 France Market Size and Forecast, by Product
  - 16.3.11.3 France Market Size and Forecast, by Services
  - 16.3.11.4 France Market Size and Forecast, by Technology
  - 16.3.11.5 France Market Size and Forecast, by Application
  - 16.3.11.6 France Market Size and Forecast, by End User
  - 16.3.11.7 France Market Size and Forecast, by Process
  - 16.3.11.8 France Market Size and Forecast, by Mode
  - 16.3.11.9 France Market Size and Forecast, by Stage
  - 16.3.11.10 Local Competition Analysis
  - 16.3.11.11 Local Market Analysis
- 16.3.1 Spain
  - 16.3.12.1 Spain Market Size and Forecast, by Type
  - 16.3.12.2 Spain Market Size and Forecast, by Product
  - 16.3.12.3 Spain Market Size and Forecast, by Services
  - 16.3.12.4 Spain Market Size and Forecast, by Technology
  - 16.3.12.5 Spain Market Size and Forecast, by Application
  - 16.3.12.6 Spain Market Size and Forecast, by End User
  - 16.3.12.7 Spain Market Size and Forecast, by Process
  - 16.3.12.8 Spain Market Size and Forecast, by Mode
  - 16.3.12.9 Spain Market Size and Forecast, by Stage
  - 16.3.12.10 Local Competition Analysis
  - 16.3.12.11 Local Market Analysis
- 16.3.1 Italy
  - 16.3.13.1 Italy Market Size and Forecast, by Type
  - 16.3.13.2 Italy Market Size and Forecast, by Product
  - 16.3.13.3 Italy Market Size and Forecast, by Services
  - 16.3.13.4 Italy Market Size and Forecast, by Technology
  - 16.3.13.5 Italy Market Size and Forecast, by Application
  - 16.3.13.6 Italy Market Size and Forecast, by End User
  - 16.3.13.7 Italy Market Size and Forecast, by Process
  - 16.3.13.8 Italy Market Size and Forecast, by Mode
  - 16.3.13.9 Italy Market Size and Forecast, by Stage
  - 16.3.13.10 Local Competition Analysis
  - 16.3.13.11 Local Market Analysis
- 16.3.1 Netherlands
  - 16.3.14.1 Netherlands Market Size and Forecast, by Type
  - 16.3.14.2 Netherlands Market Size and Forecast, by Product
  - 16.3.14.3 Netherlands Market Size and Forecast, by Services
  - 16.3.14.4 Netherlands Market Size and Forecast, by Technology
  - 16.3.14.5 Netherlands Market Size and Forecast, by Application
  - 16.3.14.6 Netherlands Market Size and Forecast, by End User
  - 16.3.14.7 Netherlands Market Size and Forecast, by Process
  - 16.3.14.8 Netherlands Market Size and Forecast, by Mode
  - 16.3.14.9 Netherlands Market Size and Forecast, by Stage
  - 16.3.14.10 Local Competition Analysis
  - 16.3.14.11 Local Market Analysis
- 16.3.1 Sweden
  - 16.3.15.1 Sweden Market Size and Forecast, by Type
  - 16.3.15.2 Sweden Market Size and Forecast, by Product
  - 16.3.15.3 Sweden Market Size and Forecast, by Services
  - 16.3.15.4 Sweden Market Size and Forecast, by Technology
  - 16.3.15.5 Sweden Market Size and Forecast, by Application
  - 16.3.15.6 Sweden Market Size and Forecast, by End User
  - 16.3.15.7 Sweden Market Size and Forecast, by Process
  - 16.3.15.8 Sweden Market Size and Forecast, by Mode
  - 16.3.15.9 Sweden Market Size and Forecast, by Stage
  - 16.3.15.10 Local Competition Analysis
  - 16.3.15.11 Local Market Analysis
- 16.3.1 Switzerland
  - 16.3.16.1 Switzerland Market Size and Forecast, by Type
  - 16.3.16.2 Switzerland Market Size and Forecast, by Product
  - 16.3.16.3 Switzerland Market Size and Forecast, by Services
  - 16.3.16.4 Switzerland Market Size and Forecast, by Technology
  - 16.3.16.5 Switzerland Market Size and Forecast, by Application
  - 16.3.16.6 Switzerland Market Size and Forecast, by End User
  - 16.3.16.7 Switzerland Market Size and Forecast, by Process
  - 16.3.16.8 Switzerland Market Size and Forecast, by Mode
  - 16.3.16.9 Switzerland Market Size and Forecast, by Stage
  - 16.3.16.10 Local Competition Analysis
  - 16.3.16.11 Local Market Analysis
- 16.3.1 Denmark
  - 16.3.17.1 Denmark Market Size and Forecast, by Type
  - 16.3.17.2 Denmark Market Size and Forecast, by Product
  - 16.3.17.3 Denmark Market Size and Forecast, by Services
  - 16.3.17.4 Denmark Market Size and Forecast, by Technology
  - 16.3.17.5 Denmark Market Size and Forecast, by Application
  - 16.3.17.6 Denmark Market Size and Forecast, by End User
  - 16.3.17.7 Denmark Market Size and Forecast, by Process
  - 16.3.17.8 Denmark Market Size and Forecast, by Mode
  - 16.3.17.9 Denmark Market Size and Forecast, by Stage
  - 16.3.17.10 Local Competition Analysis
  - 16.3.17.11 Local Market Analysis
- 16.3.1 Finland
  - 16.3.18.1 Finland Market Size and Forecast, by Type
  - 16.3.18.2 Finland Market Size and Forecast, by Product
  - 16.3.18.3 Finland Market Size and Forecast, by Services
  - 16.3.18.4 Finland Market Size and Forecast, by Technology
  - 16.3.18.5 Finland Market Size and Forecast, by Application
  - 16.3.18.6 Finland Market Size and Forecast, by End User
  - 16.3.18.7 Finland Market Size and Forecast, by Process
  - 16.3.18.8 Finland Market Size and Forecast, by Mode
  - 16.3.18.9 Finland Market Size and Forecast, by Stage
  - 16.3.18.10 Local Competition Analysis
  - 16.3.18.11 Local Market Analysis
- 16.3.1 Russia
  - 16.3.19.1 Russia Market Size and Forecast, by Type
  - 16.3.19.2 Russia Market Size and Forecast, by Product
  - 16.3.19.3 Russia Market Size and Forecast, by Services
  - 16.3.19.4 Russia Market Size and Forecast, by Technology
  - 16.3.19.5 Russia Market Size and Forecast, by Application
  - 16.3.19.6 Russia Market Size and Forecast, by End User
  - 16.3.19.7 Russia Market Size and Forecast, by Process
  - 16.3.19.8 Russia Market Size and Forecast, by Mode
  - 16.3.19.9 Russia Market Size and Forecast, by Stage
  - 16.3.19.10 Local Competition Analysis
  - 16.3.19.11 Local Market Analysis
- 16.3.1 Rest of Europe
  - 16.3.20.1 Rest of Europe Market Size and Forecast, by Type
  - 16.3.20.2 Rest of Europe Market Size and Forecast, by Product
  - 16.3.20.3 Rest of Europe Market Size and Forecast, by Services
  - 16.3.20.4 Rest of Europe Market Size and Forecast, by Technology
  - 16.3.20.5 Rest of Europe Market Size and Forecast, by Application
  - 16.3.20.6 Rest of Europe Market Size and Forecast, by End User
  - 16.3.20.7 Rest of Europe Market Size and Forecast, by Process
  - 16.3.20.8 Rest of Europe Market Size and Forecast, by Mode
  - 16.3.20.9 Rest of Europe Market Size and Forecast, by Stage
  - 16.3.20.10 Local Competition Analysis
  - 16.3.20.11 Local Market Analysis
16.1 Asia-Pacific
- 16.4.1 Key Market Trends and Opportunities
- 16.4.2 Asia-Pacific Market Size and Forecast, by Type
- 16.4.3 Asia-Pacific Market Size and Forecast, by Product
- 16.4.4 Asia-Pacific Market Size and Forecast, by Services
- 16.4.5 Asia-Pacific Market Size and Forecast, by Technology
- 16.4.6 Asia-Pacific Market Size and Forecast, by Application
- 16.4.7 Asia-Pacific Market Size and Forecast, by End User
- 16.4.8 Asia-Pacific Market Size and Forecast, by Process
- 16.4.9 Asia-Pacific Market Size and Forecast, by Mode
- 16.4.10 Asia-Pacific Market Size and Forecast, by Stage
- 16.4.11 Asia-Pacific Market Size and Forecast, by Country
- 16.4.12 China
  - 16.4.9.1 China Market Size and Forecast, by Type
  - 16.4.9.2 China Market Size and Forecast, by Product
  - 16.4.9.3 China Market Size and Forecast, by Services
  - 16.4.9.4 China Market Size and Forecast, by Technology
  - 16.4.9.5 China Market Size and Forecast, by Application
  - 16.4.9.6 China Market Size and Forecast, by End User
  - 16.4.9.7 China Market Size and Forecast, by Process
  - 16.4.9.8 China Market Size and Forecast, by Mode
  - 16.4.9.9 China Market Size and Forecast, by Stage
  - 16.4.9.10 Local Competition Analysis
  - 16.4.9.11 Local Market Analysis
- 16.4.1 India
  - 16.4.10.1 India Market Size and Forecast, by Type
  - 16.4.10.2 India Market Size and Forecast, by Product
  - 16.4.10.3 India Market Size and Forecast, by Services
  - 16.4.10.4 India Market Size and Forecast, by Technology
  - 16.4.10.5 India Market Size and Forecast, by Application
  - 16.4.10.6 India Market Size and Forecast, by End User
  - 16.4.10.7 India Market Size and Forecast, by Process
  - 16.4.10.8 India Market Size and Forecast, by Mode
  - 16.4.10.9 India Market Size and Forecast, by Stage
  - 16.4.10.10 Local Competition Analysis
  - 16.4.10.11 Local Market Analysis
- 16.4.1 Japan
  - 16.4.11.1 Japan Market Size and Forecast, by Type
  - 16.4.11.2 Japan Market Size and Forecast, by Product
  - 16.4.11.3 Japan Market Size and Forecast, by Services
  - 16.4.11.4 Japan Market Size and Forecast, by Technology
  - 16.4.11.5 Japan Market Size and Forecast, by Application
  - 16.4.11.6 Japan Market Size and Forecast, by End User
  - 16.4.11.7 Japan Market Size and Forecast, by Process
  - 16.4.11.8 Japan Market Size and Forecast, by Mode
  - 16.4.11.9 Japan Market Size and Forecast, by Stage
  - 16.4.11.10 Local Competition Analysis
  - 16.4.11.11 Local Market Analysis
- 16.4.1 South Korea
  - 16.4.12.1 South Korea Market Size and Forecast, by Type
  - 16.4.12.2 South Korea Market Size and Forecast, by Product
  - 16.4.12.3 South Korea Market Size and Forecast, by Services
  - 16.4.12.4 South Korea Market Size and Forecast, by Technology
  - 16.4.12.5 South Korea Market Size and Forecast, by Application
  - 16.4.12.6 South Korea Market Size and Forecast, by End User
  - 16.4.12.7 South Korea Market Size and Forecast, by Process
  - 16.4.12.8 South Korea Market Size and Forecast, by Mode
  - 16.4.12.9 South Korea Market Size and Forecast, by Stage
  - 16.4.12.10 Local Competition Analysis
  - 16.4.12.11 Local Market Analysis
- 16.4.1 Australia
  - 16.4.13.1 Australia Market Size and Forecast, by Type
  - 16.4.13.2 Australia Market Size and Forecast, by Product
  - 16.4.13.3 Australia Market Size and Forecast, by Services
  - 16.4.13.4 Australia Market Size and Forecast, by Technology
  - 16.4.13.5 Australia Market Size and Forecast, by Application
  - 16.4.13.6 Australia Market Size and Forecast, by End User
  - 16.4.13.7 Australia Market Size and Forecast, by Process
  - 16.4.13.8 Australia Market Size and Forecast, by Mode
  - 16.4.13.9 Australia Market Size and Forecast, by Stage
  - 16.4.13.10 Local Competition Analysis
  - 16.4.13.11 Local Market Analysis
- 16.4.1 Singapore
  - 16.4.14.1 Singapore Market Size and Forecast, by Type
  - 16.4.14.2 Singapore Market Size and Forecast, by Product
  - 16.4.14.3 Singapore Market Size and Forecast, by Services
  - 16.4.14.4 Singapore Market Size and Forecast, by Technology
  - 16.4.14.5 Singapore Market Size and Forecast, by Application
  - 16.4.14.6 Singapore Market Size and Forecast, by End User
  - 16.4.14.7 Singapore Market Size and Forecast, by Process
  - 16.4.14.8 Singapore Market Size and Forecast, by Mode
  - 16.4.14.9 Singapore Market Size and Forecast, by Stage
  - 16.4.14.10 Local Competition Analysis
  - 16.4.14.11 Local Market Analysis
- 16.4.1 Indonesia
  - 16.4.15.1 Indonesia Market Size and Forecast, by Type
  - 16.4.15.2 Indonesia Market Size and Forecast, by Product
  - 16.4.15.3 Indonesia Market Size and Forecast, by Services
  - 16.4.15.4 Indonesia Market Size and Forecast, by Technology
  - 16.4.15.5 Indonesia Market Size and Forecast, by Application
  - 16.4.15.6 Indonesia Market Size and Forecast, by End User
  - 16.4.15.7 Indonesia Market Size and Forecast, by Process
  - 16.4.15.8 Indonesia Market Size and Forecast, by Mode
  - 16.4.15.9 Indonesia Market Size and Forecast, by Stage
  - 16.4.15.10 Local Competition Analysis
  - 16.4.15.11 Local Market Analysis
- 16.4.1 Taiwan
  - 16.4.16.1 Taiwan Market Size and Forecast, by Type
  - 16.4.16.2 Taiwan Market Size and Forecast, by Product
  - 16.4.16.3 Taiwan Market Size and Forecast, by Services
  - 16.4.16.4 Taiwan Market Size and Forecast, by Technology
  - 16.4.16.5 Taiwan Market Size and Forecast, by Application
  - 16.4.16.6 Taiwan Market Size and Forecast, by End User
  - 16.4.16.7 Taiwan Market Size and Forecast, by Process
  - 16.4.16.8 Taiwan Market Size and Forecast, by Mode
  - 16.4.16.9 Taiwan Market Size and Forecast, by Stage
  - 16.4.16.10 Local Competition Analysis
  - 16.4.16.11 Local Market Analysis
- 16.4.1 Malaysia
  - 16.4.17.1 Malaysia Market Size and Forecast, by Type
  - 16.4.17.2 Malaysia Market Size and Forecast, by Product
  - 16.4.17.3 Malaysia Market Size and Forecast, by Services
  - 16.4.17.4 Malaysia Market Size and Forecast, by Technology
  - 16.4.17.5 Malaysia Market Size and Forecast, by Application
  - 16.4.17.6 Malaysia Market Size and Forecast, by End User
  - 16.4.17.7 Malaysia Market Size and Forecast, by Process
  - 16.4.17.8 Malaysia Market Size and Forecast, by Mode
  - 16.4.17.9 Malaysia Market Size and Forecast, by Stage
  - 16.4.17.10 Local Competition Analysis
  - 16.4.17.11 Local Market Analysis
- 16.4.1 Rest of Asia-Pacific
  - 16.4.18.1 Rest of Asia-Pacific Market Size and Forecast, by Type
  - 16.4.18.2 Rest of Asia-Pacific Market Size and Forecast, by Product
  - 16.4.18.3 Rest of Asia-Pacific Market Size and Forecast, by Services
  - 16.4.18.4 Rest of Asia-Pacific Market Size and Forecast, by Technology
  - 16.4.18.5 Rest of Asia-Pacific Market Size and Forecast, by Application
  - 16.4.18.6 Rest of Asia-Pacific Market Size and Forecast, by End User
  - 16.4.18.7 Rest of Asia-Pacific Market Size and Forecast, by Process
  - 16.4.18.8 Rest of Asia-Pacific Market Size and Forecast, by Mode
  - 16.4.18.9 Rest of Asia-Pacific Market Size and Forecast, by Stage
  - 16.4.18.10 Local Competition Analysis
  - 16.4.18.11 Local Market Analysis
16.1 Latin America
- 16.5.1 Key Market Trends and Opportunities
- 16.5.2 Latin America Market Size and Forecast, by Type
- 16.5.3 Latin America Market Size and Forecast, by Product
- 16.5.4 Latin America Market Size and Forecast, by Services
- 16.5.5 Latin America Market Size and Forecast, by Technology
- 16.5.6 Latin America Market Size and Forecast, by Application
- 16.5.7 Latin America Market Size and Forecast, by End User
- 16.5.8 Latin America Market Size and Forecast, by Process
- 16.5.9 Latin America Market Size and Forecast, by Mode
- 16.5.10 Latin America Market Size and Forecast, by Stage
- 16.5.11 Latin America Market Size and Forecast, by Country
- 16.5.12 Brazil
  - 16.5.9.1 Brazil Market Size and Forecast, by Type
  - 16.5.9.2 Brazil Market Size and Forecast, by Product
  - 16.5.9.3 Brazil Market Size and Forecast, by Services
  - 16.5.9.4 Brazil Market Size and Forecast, by Technology
  - 16.5.9.5 Brazil Market Size and Forecast, by Application
  - 16.5.9.6 Brazil Market Size and Forecast, by End User
  - 16.5.9.7 Brazil Market Size and Forecast, by Process
  - 16.5.9.8 Brazil Market Size and Forecast, by Mode
  - 16.5.9.9 Brazil Market Size and Forecast, by Stage
  - 16.5.9.10 Local Competition Analysis
  - 16.5.9.11 Local Market Analysis
- 16.5.1 Mexico
  - 16.5.10.1 Mexico Market Size and Forecast, by Type
  - 16.5.10.2 Mexico Market Size and Forecast, by Product
  - 16.5.10.3 Mexico Market Size and Forecast, by Services
  - 16.5.10.4 Mexico Market Size and Forecast, by Technology
  - 16.5.10.5 Mexico Market Size and Forecast, by Application
  - 16.5.10.6 Mexico Market Size and Forecast, by End User
  - 16.5.10.7 Mexico Market Size and Forecast, by Process
  - 16.5.10.8 Mexico Market Size and Forecast, by Mode
  - 16.5.10.9 Mexico Market Size and Forecast, by Stage
  - 16.5.10.10 Local Competition Analysis
  - 16.5.10.11 Local Market Analysis
- 16.5.1 Argentina
  - 16.5.11.1 Argentina Market Size and Forecast, by Type
  - 16.5.11.2 Argentina Market Size and Forecast, by Product
  - 16.5.11.3 Argentina Market Size and Forecast, by Services
  - 16.5.11.4 Argentina Market Size and Forecast, by Technology
  - 16.5.11.5 Argentina Market Size and Forecast, by Application
  - 16.5.11.6 Argentina Market Size and Forecast, by End User
  - 16.5.11.7 Argentina Market Size and Forecast, by Process
  - 16.5.11.8 Argentina Market Size and Forecast, by Mode
  - 16.5.11.9 Argentina Market Size and Forecast, by Stage
  - 16.5.11.10 Local Competition Analysis
  - 16.5.11.11 Local Market Analysis
- 16.5.1 Rest of Latin America
  - 16.5.12.1 Rest of Latin America Market Size and Forecast, by Type
  - 16.5.12.2 Rest of Latin America Market Size and Forecast, by Product
  - 16.5.12.3 Rest of Latin America Market Size and Forecast, by Services
  - 16.5.12.4 Rest of Latin America Market Size and Forecast, by Technology
  - 16.5.12.5 Rest of Latin America Market Size and Forecast, by Application
  - 16.5.12.6 Rest of Latin America Market Size and Forecast, by End User
  - 16.5.12.7 Rest of Latin America Market Size and Forecast, by Process
  - 16.5.12.8 Rest of Latin America Market Size and Forecast, by Mode
  - 16.5.12.9 Rest of Latin America Market Size and Forecast, by Stage
  - 16.5.12.10 Local Competition Analysis
  - 16.5.12.11 Local Market Analysis
16.1 Middle East and Africa
- 16.6.1 Key Market Trends and Opportunities
- 16.6.2 Middle East and Africa Market Size and Forecast, by Type
- 16.6.3 Middle East and Africa Market Size and Forecast, by Product
- 16.6.4 Middle East and Africa Market Size and Forecast, by Services
- 16.6.5 Middle East and Africa Market Size and Forecast, by Technology
- 16.6.6 Middle East and Africa Market Size and Forecast, by Application
- 16.6.7 Middle East and Africa Market Size and Forecast, by End User
- 16.6.8 Middle East and Africa Market Size and Forecast, by Process
- 16.6.9 Middle East and Africa Market Size and Forecast, by Mode
- 16.6.10 Middle East and Africa Market Size and Forecast, by Stage
- 16.6.11 Middle East and Africa Market Size and Forecast, by Country
- 16.6.12 Saudi Arabia
  - 16.6.9.1 Saudi Arabia Market Size and Forecast, by Type
  - 16.6.9.2 Saudi Arabia Market Size and Forecast, by Product
  - 16.6.9.3 Saudi Arabia Market Size and Forecast, by Services
  - 16.6.9.4 Saudi Arabia Market Size and Forecast, by Technology
  - 16.6.9.5 Saudi Arabia Market Size and Forecast, by Application
  - 16.6.9.6 Saudi Arabia Market Size and Forecast, by End User
  - 16.6.9.7 Saudi Arabia Market Size and Forecast, by Process
  - 16.6.9.8 Saudi Arabia Market Size and Forecast, by Mode
  - 16.6.9.9 Saudi Arabia Market Size and Forecast, by Stage
  - 16.6.9.10 Local Competition Analysis
  - 16.6.9.11 Local Market Analysis
- 16.6.1 UAE
  - 16.6.10.1 UAE Market Size and Forecast, by Type
  - 16.6.10.2 UAE Market Size and Forecast, by Product
  - 16.6.10.3 UAE Market Size and Forecast, by Services
  - 16.6.10.4 UAE Market Size and Forecast, by Technology
  - 16.6.10.5 UAE Market Size and Forecast, by Application
  - 16.6.10.6 UAE Market Size and Forecast, by End User
  - 16.6.10.7 UAE Market Size and Forecast, by Process
  - 16.6.10.8 UAE Market Size and Forecast, by Mode
  - 16.6.10.9 UAE Market Size and Forecast, by Stage
  - 16.6.10.10 Local Competition Analysis
  - 16.6.10.11 Local Market Analysis
- 16.6.1 South Africa
  - 16.6.11.1 South Africa Market Size and Forecast, by Type
  - 16.6.11.2 South Africa Market Size and Forecast, by Product
  - 16.6.11.3 South Africa Market Size and Forecast, by Services
  - 16.6.11.4 South Africa Market Size and Forecast, by Technology
  - 16.6.11.5 South Africa Market Size and Forecast, by Application
  - 16.6.11.6 South Africa Market Size and Forecast, by End User
  - 16.6.11.7 South Africa Market Size and Forecast, by Process
  - 16.6.11.8 South Africa Market Size and Forecast, by Mode
  - 16.6.11.9 South Africa Market Size and Forecast, by Stage
  - 16.6.11.10 Local Competition Analysis
  - 16.6.11.11 Local Market Analysis
- 16.6.1 Rest of MEA
  - 16.6.12.1 Rest of MEA Market Size and Forecast, by Type
  - 16.6.12.2 Rest of MEA Market Size and Forecast, by Product
  - 16.6.12.3 Rest of MEA Market Size and Forecast, by Services
  - 16.6.12.4 Rest of MEA Market Size and Forecast, by Technology
  - 16.6.12.5 Rest of MEA Market Size and Forecast, by Application
  - 16.6.12.6 Rest of MEA Market Size and Forecast, by End User
  - 16.6.12.7 Rest of MEA Market Size and Forecast, by Process
  - 16.6.12.8 Rest of MEA Market Size and Forecast, by Mode
  - 16.6.12.9 Rest of MEA Market Size and Forecast, by Stage
  - 16.6.12.10 Local Competition Analysis
  - 16.6.12.11 Local Market Analysis

17: Competitive Landscape

17.1 Overview
17.2 Market Share Analysis
17.3 Key Player Positioning
17.4 Competitive Leadership Mapping
- 17.4.1 Star Players
- 17.4.2 Innovators
- 17.4.3 Emerging Players
17.5 Vendor Benchmarking
17.6 Developmental Strategy Benchmarking
- 17.6.1 New Product Developments
- 17.6.2 Product Launches
- 17.6.3 Business Expansions
- 17.6.4 Partnerships, Joint Ventures, and Collaborations
- 17.6.5 Mergers and Acquisitions

18: Company Profiles

18.1 Bluebird Bio
- 18.1.1 Company Overview
- 18.1.2 Company Snapshot
- 18.1.3 Business Segments
- 18.1.4 Business Performance
- 18.1.5 Product Offerings
- 18.1.6 Key Developmental Strategies
- 18.1.7 SWOT Analysis
18.2 Sangamo Therapeutics
- 18.2.1 Company Overview
- 18.2.2 Company Snapshot
- 18.2.3 Business Segments
- 18.2.4 Business Performance
- 18.2.5 Product Offerings
- 18.2.6 Key Developmental Strategies
- 18.2.7 SWOT Analysis
18.3 Adaptimmune Therapeutics
- 18.3.1 Company Overview
- 18.3.2 Company Snapshot
- 18.3.3 Business Segments
- 18.3.4 Business Performance
- 18.3.5 Product Offerings
- 18.3.6 Key Developmental Strategies
- 18.3.7 SWOT Analysis
18.4 Atara Biotherapeutics
- 18.4.1 Company Overview
- 18.4.2 Company Snapshot
- 18.4.3 Business Segments
- 18.4.4 Business Performance
- 18.4.5 Product Offerings
- 18.4.6 Key Developmental Strategies
- 18.4.7 SWOT Analysis
18.5 Cellectis
- 18.5.1 Company Overview
- 18.5.2 Company Snapshot
- 18.5.3 Business Segments
- 18.5.4 Business Performance
- 18.5.5 Product Offerings
- 18.5.6 Key Developmental Strategies
- 18.5.7 SWOT Analysis
18.6 Fate Therapeutics
- 18.6.1 Company Overview
- 18.6.2 Company Snapshot
- 18.6.3 Business Segments
- 18.6.4 Business Performance
- 18.6.5 Product Offerings
- 18.6.6 Key Developmental Strategies
- 18.6.7 SWOT Analysis
18.7 Gamida Cell
- 18.7.1 Company Overview
- 18.7.2 Company Snapshot
- 18.7.3 Business Segments
- 18.7.4 Business Performance
- 18.7.5 Product Offerings
- 18.7.6 Key Developmental Strategies
- 18.7.7 SWOT Analysis
18.8 Kiadis Pharma
- 18.8.1 Company Overview
- 18.8.2 Company Snapshot
- 18.8.3 Business Segments
- 18.8.4 Business Performance
- 18.8.5 Product Offerings
- 18.8.6 Key Developmental Strategies
- 18.8.7 SWOT Analysis
18.9 Mesoblast
- 18.9.1 Company Overview
- 18.9.2 Company Snapshot
- 18.9.3 Business Segments
- 18.9.4 Business Performance
- 18.9.5 Product Offerings
- 18.9.6 Key Developmental Strategies
- 18.9.7 SWOT Analysis
18.10 Orchard Therapeutics
- 18.10.1 Company Overview
- 18.10.2 Company Snapshot
- 18.10.3 Business Segments
- 18.10.4 Business Performance
- 18.10.5 Product Offerings
- 18.10.6 Key Developmental Strategies
- 18.10.7 SWOT Analysis
18.11 Poseida Therapeutics
- 18.11.1 Company Overview
- 18.11.2 Company Snapshot
- 18.11.3 Business Segments
- 18.11.4 Business Performance
- 18.11.5 Product Offerings
- 18.11.6 Key Developmental Strategies
- 18.11.7 SWOT Analysis
18.12 Precision BioSciences
- 18.12.1 Company Overview
- 18.12.2 Company Snapshot
- 18.12.3 Business Segments
- 18.12.4 Business Performance
- 18.12.5 Product Offerings
- 18.12.6 Key Developmental Strategies
- 18.12.7 SWOT Analysis
18.13 Regenxbio
- 18.13.1 Company Overview
- 18.13.2 Company Snapshot
- 18.13.3 Business Segments
- 18.13.4 Business Performance
- 18.13.5 Product Offerings
- 18.13.6 Key Developmental Strategies
- 18.13.7 SWOT Analysis
18.14 Rubius Therapeutics
- 18.14.1 Company Overview
- 18.14.2 Company Snapshot
- 18.14.3 Business Segments
- 18.14.4 Business Performance
- 18.14.5 Product Offerings
- 18.14.6 Key Developmental Strategies
- 18.14.7 SWOT Analysis
18.15 Sorrento Therapeutics
- 18.15.1 Company Overview
- 18.15.2 Company Snapshot
- 18.15.3 Business Segments
- 18.15.4 Business Performance
- 18.15.5 Product Offerings
- 18.15.6 Key Developmental Strategies
- 18.15.7 SWOT Analysis
18.16 TCR2 Therapeutics
- 18.16.1 Company Overview
- 18.16.2 Company Snapshot
- 18.16.3 Business Segments
- 18.16.4 Business Performance
- 18.16.5 Product Offerings
- 18.16.6 Key Developmental Strategies
- 18.16.7 SWOT Analysis
18.17 Unum Therapeutics
- 18.17.1 Company Overview
- 18.17.2 Company Snapshot
- 18.17.3 Business Segments
- 18.17.4 Business Performance
- 18.17.5 Product Offerings
- 18.17.6 Key Developmental Strategies
- 18.17.7 SWOT Analysis
18.18 Vericel
- 18.18.1 Company Overview
- 18.18.2 Company Snapshot
- 18.18.3 Business Segments
- 18.18.4 Business Performance
- 18.18.5 Product Offerings
- 18.18.6 Key Developmental Strategies
- 18.18.7 SWOT Analysis
18.19 Ziopharm Oncology
- 18.19.1 Company Overview
- 18.19.2 Company Snapshot
- 18.19.3 Business Segments
- 18.19.4 Business Performance
- 18.19.5 Product Offerings
- 18.19.6 Key Developmental Strategies
- 18.19.7 SWOT Analysis
18.20 Allogene Therapeutics
- 18.20.1 Company Overview
- 18.20.2 Company Snapshot
- 18.20.3 Business Segments
- 18.20.4 Business Performance
- 18.20.5 Product Offerings
- 18.20.6 Key Developmental Strategies
- 18.20.7 SWOT Analysis

細胞療法の世界市場分析と予測（～2033年）：タイプ、製品、サービス、技術、用途、エンドユーザー、プロセス、方法、ステージ

Cell Therapy Market Analysis and Forecast to 2033: Type, Product, Services, Technology, Application, End User, Process, Mode, Stage

目次

第1章 細胞療法市場の概要

第2章 エグゼクティブサマリー

第3章 市場に関する重要考察

第4章 細胞療法市場の展望

第5章 細胞療法市場戦略

第6章 細胞療法の市場規模

第7章 細胞療法市場：タイプ別

第8章 細胞療法市場：製品別

第9章 細胞療法市場：サービス別

第10章 細胞療法市場：技術別

第11章 細胞療法市場：用途別

第12章 細胞療法市場：エンドユーザー別

第13章 細胞療法市場：プロセス別

第14章 細胞療法市場：方法別

第15章 細胞療法市場：ステージ別

第16章 細胞療法市場：地域別

第17章 競合情勢

第18章 企業プロファイル

Key Companies

Sources

Research Scope

TABLE OF CONTENTS

1: Cell Therapy Market Overview

2: Executive Summary

3: Premium Insights on the Market

4: Cell Therapy Market Outlook

5: Cell Therapy Market Strategy

6: Cell Therapy Market Size

7: Cell Therapy Market, by Type

8: Cell Therapy Market, by Product

9: Cell Therapy Market, by Services

10: Cell Therapy Market, by Technology

11: Cell Therapy Market, by Application

12: Cell Therapy Market, by End User

13: Cell Therapy Market, by Process

14: Cell Therapy Market, by Mode

15: Cell Therapy Market, by Stage

16: Cell Therapy Market, by Region

17: Competitive Landscape

18: Company Profiles

第1章細胞療法市場の概要

第2章エグゼクティブサマリー

第3章市場に関する重要考察

第4章細胞療法市場の展望

第5章細胞療法市場戦略

第6章細胞療法の市場規模

第7章細胞療法市場：タイプ別

第8章細胞療法市場：製品別

第9章細胞療法市場：サービス別

第10章細胞療法市場：技術別

第11章細胞療法市場：用途別

第12章細胞療法市場：エンドユーザー別

第13章細胞療法市場：プロセス別

第14章細胞療法市場：方法別

第15章細胞療法市場：ステージ別

第16章細胞療法市場：地域別

第17章競合情勢

第18章企業プロファイル